financetom
Business
financetom
/
Business
/
Update: Sagicor Financial Up 3.1% As Q4 Boosted By Ivari Buy, Raises Dividend by 7%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Sagicor Financial Up 3.1% As Q4 Boosted By Ivari Buy, Raises Dividend by 7%
Apr 1, 2024 9:42 AM

12:16 PM EDT, 04/01/2024 (MT Newswires) -- Sagicor Financial ( SGCFF ) , traded at a 52-week high at last look after over the holiday weekend reporting fourth-quarter a fourth-quarter profit of US$485.3 million, up from US$71.9 million in the year-ago quarter.

ISagicor said the results "significantly benefited" from the ivari acquisition and subsidiaries' "strong" aggregate Q4 results. Of the net income to shareholders of $485.3 million, the bargain purchase gain on the ivari acquisition contributed $448.3 million. Net income to shareholders excluding this gain and associated transaction costs was US$51.2 million.

New business contractual service margin (CSM) was US$34.8 million, down from US$40.1 million in the year-ago quarter.

The company expects core net income to shareholders for 2024 of US$90 million to US$105 million. New business CSM for 2024 is targeted at US$180 million to US$200 million.

For 2025, growth in core net income to shareholders is targeted at over 10% above 2024 levels.

In addition, Sagicor's board of directors declared a quarterly dividend of US$0.06 per common share, an increase of 7%, to be paid April 30 to shareholders of record at the close of business on April 10.

Sagicor is a financial services provider in the Caribbean and Canada, with a growing presence in the US.

The company's shares were last seen up C$0.22 to C$7,24 on the Toronto Stock Exchange, a 52-week high.

Price: 7.24, Change: +0.22, Percent Change: +3.13

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merck lowers mid-term healthcare outlook after recent drug failures
Merck lowers mid-term healthcare outlook after recent drug failures
Oct 17, 2024
Oct 17 (Reuters) - German science and technology company Merck ( MRK ) lowered mid-term targets for its Life Sciences and Healthcare businesses, anticipating an update on China's growth prospects and following a string of setbacks in its drug development. The company narrowed expectations for its Life Science business, aiming for a 7-9% range from a previously anticipated 7-10%, it...
Rentokil expects hit to 2025 profit on delay in Terminix deal synergy
Rentokil expects hit to 2025 profit on delay in Terminix deal synergy
Oct 17, 2024
Oct 17 (Reuters) - British pest control company Rentokil Initial ( RTO ) said on Thursday its profit and margins in 2025 will be hurt by a delay of about two to three months in realizing synergies from its acquisition U.S. rival Terminix. (Reporting by Yamini Kalia in Bengaluru; Editing by Subhranshu Sahu) ...
Hyundai Motor India set to price shares at top of range to raise $3.3 billion, sources say
Hyundai Motor India set to price shares at top of range to raise $3.3 billion, sources say
Oct 17, 2024
(Reuters) -Hyundai Motor India is set to price its shares at 1,960 rupees to raise $3.3 billion in its initial public offering, according to two sources with direct knowledge of the matter. That price is at the top of the 1,865 rupees to 1,960 rupees range flagged to investors when the deal was launched. Hyundai India is selling 142.2 million...
Carlyle-backed Rigaku raises $863 mln in Tokyo IPO
Carlyle-backed Rigaku raises $863 mln in Tokyo IPO
Oct 17, 2024
TOKYO, Oct 17 (Reuters) - Rigaku Holdings raised 129 billion yen ($863 million) after the Japan X-ray testing tool maker priced its IPO at the top of its range, according to a regulatory filing on Thursday. The company, which is backed by buyout firm Carlyle Group ( CG ), priced the IPO at 1,260 yen per share, at the top...
Copyright 2023-2026 - www.financetom.com All Rights Reserved